Filter By:

Choose an area from the filter to limit results to that area and show available options for further filtering

Funding Awarded

4 awards

  • HRB Collaboration in Ireland for Clinical Effectiveness Reviews (HRB-CICER)

    Through the National Clinical Effectiveness Committee (NCEC), the Minister for Health mandates clinical guidelines as National Clinical Guidelines for use in public healthcare in Ireland. The goal of the guidelines is to promote healthcare that is current, effective and consistent, ensuring best outcomes for patients and service users....

  • What is Alpha-1?

    Alpha-1 antitrypsin deficiency (Alpha-1) is a genetic disorder that affects the lungs. Typically people with Alpha-1 present with chronic obstructive pulmonary disease (COPD) or severe asthma. Ireland has one of the highest rates of AATD in the world. 1 in 25 Irish people are carriers for the condition and are at risk of lung disease,...

  • Altered lipid raft cholesterol content contributes to the dysregulated activity of neutrophils in alpha-1 antitrypsin deficiency

    Alpha-1-antitrypsin (AAT) deficiency (AATD) is largely unrecognized and under diagnosed. This hereditary disorder results in the rapid progression of lung disease, especially in smokers. Specific treatment for this disorder is available in the form of weekly intravenous injections of AAT. This is referred to as augmentation therapy and...

  • Alpha-1 antitrypsin deficiency: Which is important phenotype, level, activity or all three?

    Alpha-1 antitrypsin (AAT) deficiency (AATD) is generally regarded as a rare condition but more recently, evidence points towards it being a condition that is relatively common but rarely diagnosed. The most severe form of this genetic disorder, where people carry two bad AAT genes (Z) is known as ZZ-AATD and this affects around 2000...